PB CPD Online e-learning site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (1997) 21: 394-397. doi: 10.1192/pb.21.7.394
© 1997 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, D. A. W.
Right arrow Articles by Rasmussen, J. G. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Johnson, D. A. W.
Right arrow Articles by Rasmussen, J. G. C.

Professional attitudes in the UK towards neuroleptic maintenance therapy in schizophrenia

The problem of inadequate prophylaxis

D. A. W. Johnson, Hon. Consultant

South Manchester University Hospitals (NHS) Trust, c/o 14 St John's Street, Manchester M3 4DZ

J. G. C. Rasmussen, Leacroft Medical Practice, Leacroft*

Ifield Road, West Green, Crawley, West Sussex RH11 7BS

* Correspondence

Controlled trials show that about 80% of schizophrenic patients remain relapse free when given adequate neuroleptic maintenance therapy but this level of efficacy is not achieved in clinical practice. Guidelines for proper use of neuroleptics in relapse prevention were developed by a group of experienced psychiatrists — the ‘Consensus Group’ — in 1989. In this survey, the views of UK psychiatrists, GPs, CPNs and pharmacists involved in community care of schizophrenia were compared with the Guidelines.

A substantial proportion of respondents suggested shorter periods of neuroleptic maintenance than recommended and large regional variations were apparent. The results suggest that there remains substantial professional failure to follow present guidelines or to assure adequate neuroleptic prophylaxis for schizophrenia.




This article has been cited by other articles:


Home page
Adv. Psychiatr. Treat.Home page
R. Chaplin
How can clinicians help patients to take their psychotropic medication?: Invited commentary on... Why don't patients take their medicine?
Advan. Psychiatr. Treat., September 1, 2007; 13(5): 347 - 349.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1997 The Royal College of Psychiatrists.